Shyama Herath

Title: Shyama Herath: Innovator in Pharmaceutical Research

Introduction

Shyama Herath is a prominent inventor based in San Diego, CA (US). She has made significant contributions to the field of pharmaceutical research, particularly in the development of inhibitors for PARG (Poly(ADP-ribose) glycohydrolase). Her innovative work has led to the filing of two patents that showcase her expertise and dedication to advancing medical science.

Latest Patents

Herath's latest patents include "Substituted imidazo[1,2-A]quinazolines as inhibitors of PARG" and "Substituted imidazo[1,2-a]quinazolines and imidazo [1,2-a]pyrido[4,3-e]pyrimidines as inhibitors of PARG." These patents provide detailed descriptions of the inhibitors of PARG, pharmaceutical compositions comprising these compounds, and methods for their use in treating diseases. The inhibitors have a specific structure as outlined in Formula (I), demonstrating her innovative approach to drug development.

Career Highlights

Shyama Herath is currently associated with 858 Therapeutics, Inc., where she continues to push the boundaries of pharmaceutical innovation. Her work is characterized by a commitment to finding effective treatments for various diseases through her research and development efforts.

Collaborations

Herath collaborates with notable colleagues, including James M Veal and Jeffrey A Stafford, who contribute to her research endeavors. Their combined expertise enhances the potential impact of her work in the pharmaceutical industry.

Conclusion

Shyama Herath is a trailblazer in the field of pharmaceutical research, with a focus on developing innovative treatments through her patented inventions. Her contributions are paving the way for advancements in medical science and improving patient outcomes.